XML 23 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Aug. 30, 2018
Aug. 31, 2017
Sep. 01, 2016
Cash flows from operating activities      
Net income (loss) $ 14,138 $ 5,090 $ (275)
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation expense and amortization of intangible assets 4,759 3,861 2,980
Amortization of debt discount and other costs 101 125 126
Loss on debt prepayments, repurchases, and conversions 385 99 4
Stock-based compensation 198 215 191
Gain on remeasurement of previously-held equity interest in Inotera 0 (71) 0
Change in operating assets and liabilities      
Receivables (1,734) (1,651) 465
Inventories (472) 50 (549)
Accounts payable and accrued expenses 549 564 272
Payments attributed to intercompany balances with Inotera 0 (361) 0
Deferred income taxes, net (265) (22) (15)
Other (259) 254 (31)
Net cash provided by operating activities 17,400 8,153 3,168
Cash flows from investing activities      
Expenditures for property, plant, and equipment (8,879) (4,734) (5,817)
Purchases of available-for-sale securities (760) (1,239) (1,026)
Payments to settle hedging activities (185) (274) (152)
Acquisition of Inotera 0 (2,634) 0
Proceeds from sales of available-for-sale securities 604 776 2,314
Proceeds from government incentives 355 21 16
Proceeds from maturities of available-for-sale securities 320 194 1,376
Proceeds from settlement of hedging activities 163 184 335
Other 166 169 (90)
Net cash provided by (used for) investing activities (8,216) (7,537) (3,044)
Cash flows from financing activities      
Repayments of debt (10,194) (2,558) (870)
Payments on equipment purchase contracts (206) (519) (46)
Proceeds from issuance of stock 1,655 142 48
Proceeds from issuance of debt 1,009 3,311 2,199
Proceeds from equipment sale-leaseback transactions 0 0 765
Other (40) (27) (351)
Net cash provided by (used for) financing activities (7,776) 349 1,745
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash (37) (12) 19
Net increase in cash, cash equivalents, and restricted cash 1,371 953 1,888
Cash, cash equivalents, and restricted cash at beginning of period 5,216 4,263 2,375
Cash, cash equivalents, and restricted cash at end of period 6,587 5,216 4,263
Supplemental disclosures      
Income taxes paid, net (226) (99) (90)
Interest paid, net of amounts capitalized (312) (468) (267)
Noncash investing and financing activity      
Equipment acquisitions on contracts payable and capital leases $ 84 $ 813 $ 993